Donley Matthew Maxwell
Related Filers (2)
Ownership (19)
4
Wednesday, 11/23/2022
Aurinia Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/4/2022
Aurinia Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/12/2021
Aurinia Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 1/4/2021
Aurinia Pharmaceuticals Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/13/2018
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2018
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/2/2018
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/5/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/10/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/8/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/6/2017
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/21/2016
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/18/2016
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2016
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/4/2016
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/20/2015
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 3/16/2015
Sucampo Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 3/16/2015
Sucampo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities